Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
⏸️ TMF AMP
ASX 200 Weekly Wrap: ASX back in the green
Share Gainers
These were the best performers on the ASX 200 last week
Share Fallers
The latest ASX 200 shares to be downgraded by leading brokers
Cheap Shares
Top brokers just upgraded these ASX 200 shares today
Share Market News
ASX 200 falls 2%, ASX travel shares drop heavily
Share Market News
Healius share price soars 20% on news of $500 million sale
Share Market News
ASX 200 down 0.3%: Big four banks mixed & Healius rockets on medical centre sale
Share Gainers
Why Appen, Healius, IDP Education, & Propel shares are racing higher
Share Market News
5 things to watch on the ASX 200 on Monday
Mergers & Acquisitions
Why the Healius share price will be in the spotlight tomorrow morning
Cheap Shares
Top brokers just upgraded these 3 ASX stocks to "buy"
Share Market News
Leading brokers name 3 ASX 200 shares to buy today
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
